Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | ($31.8K) | ($21.4K) | ($19.2K) | ($19.2K) | ($22.8K) | ($24.5K) | ($23.3K) | ($17.9M) | ($15.8M) | ($18.9M) | ($5,846.0K) | ($24.1M) | ($12.7M) | ($22.5M) | ($50.1M) | ($63.6M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Aadi Bioscience, Inc.'s last 12-month Free Cash Flow is ($61.0M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Aadi Bioscience, Inc.'s Free Cash Flow growth was (5.5%). The average annual Free Cash Flow growth rates for Aadi Bioscience, Inc. have been N/A over the past three years, 19.1% over the past five years.
Over the last year, Aadi Bioscience, Inc.'s Free Cash Flow growth was (5.5%), which is lower than industry growth of (0.1%). It indicates that Aadi Bioscience, Inc.'s Free Cash Flow growth is Bad.